Effects of exercise training on kinin receptors expression in rats with myocardial infarction

Reference

• Bell, R.M. and Yellon, D.M., 2003. Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and Enos. Journal of molecular and cellular cardiology, 35, 185–193.
   PubMed Web of Science ®Google Scholar
• Brown, M.D. and Hudlicka, O. 2003. Modulation of physiological angiogenesis in skeletal muscle by mechanical forces: involvement of VEGF and metalloproteinases. Angiogenesis, 6, 1–14.
   PubMedGoogle Scholar
• Buschmann, I., et al., 2003. Influence of inflammatory cytokines on arteriogenesis. Microcirculation, 10, 371–379.
   PubMed Web of Science ®Google Scholar
• Cassim, B., et al., 2009. Kallikreins, kininogens and kinin receptors on circulating and synovial fluid neutrophils: role in kinin generation in rheumatoid arthritis. Rheumatology (Oxford), 48, 490–496.
   PubMed Web of Science ®Google Scholar
• Chao, J. and Chao, L., 2005. Kallikrein–kinin in stroke, cardiovascular and renal disease. Experimental physiology, 90, 291–298.
   PubMed Web of Science ®Google Scholar
• Emanueli, C., et al., 1999. Dilated and failing cardiomyopathy in bradykinin B2 recepter knockout mice. Circulation, 100, 59–2365.
   Web of Science ®Google Scholar
• Emanueli, C., et al., 2000. Adenovirus-mediated human tissue kallikrein gene delivery induces angiogenesis in normoperfused skeletal muscle. Arteriosclerosis, thrombosis, and vascular biology, 20, 2379–2385.
   PubMed Web of Science ®Google Scholar
• Emanueli, C., et al., 2001. Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia. Circulation, 103, 125–132.
   PubMed Web of Science ®Google Scholar
• Emanueli, C., et al., 2002. Targeting kinin B1receptor for therapeutic neovascularization. Circulation, 105, 360–366.
   PubMed Web of Science ®Google Scholar
• Ferreira, J., et al., 2002. The use of kinin B1 and B2 receptor knockout mice and selective antagonists to characterize the nociceptive responses caused by kinins at the spinal level. Neuropharmacology, 43, 1188–1197.
   PubMed Web of Science ®Google Scholar
• Griol-Charhbili, V., et al., 2005. Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia. FASEB journal, 19, 1172–1174.
   PubMed Web of Science ®Google Scholar
• Helisch, A. and Schaper, S., 2003. Arteriogenesis: the development and growth of collateral arteries. Microcirculation, 10, 83–97.
   PubMed Web of Science ®Google Scholar
• Kränkel, N., et al., 2008. Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential. Circulation research, 103, 1335–1343.
   PubMed Web of Science ®Google Scholar
• Marcondes, S. and Antunes, E., 2005. The plasma and tissue kininogen–kallikrein–kinin system: role in the cardiovascular system. Current medicinal chemistry – cardiovascular & hematological agents, 3, 33–44.
   PubMedGoogle Scholar
• Meneton, P., et al., 2001. Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice. Proceedings of the national academy of sciences of the United States of America, 98, 2634–2639.
   PubMed Web of Science ®Google Scholar
• Morbidelli, L., et al., 1998. B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects. British journal of pharmacology 124, 1286–1292.
   PubMed Web of Science ®Google Scholar
• Munk, V.C., et al., 2007. Angiotensin II induces angiogenesis in the hypoxic adult mouse heart in vitro through an AT2-B2 receptor pathway. Hypertension, 49, 1178–1185.
   PubMed Web of Science ®Google Scholar
• Parenti, A., et al., 2001. The bradykinin/B1 receptor promotes angiogenesis by up-regulation of endogenous FGF-2 in endothelium via the nitric oxide synthase pathway. FASEB journal, 15, 1487–1489.
   PubMed Web of Science ®Google Scholar
• Pontes, F.L., Jr, et al., 2008. Kallikrein kinin system activation in post-exercise hypotension in water running of hypertensive volunteers. International immunopharmacology, 8, 261–266.
   PubMed Web of Science ®Google Scholar
• Qiu, L., et al., 2013. Bradykinin attenuates mechanical stress-induced myocardial hypertrophy through inhibiting the Ca2+/calcineurin pathway. Zhonghua xin xue guan bing za zhi, 41, 315–319.
   PubMedGoogle Scholar
• Sanchez de Miguel, L., et al., 2008. B2-kinin receptor plays a key role in B1-, angiotensin converting enzyme inhibitor-, and vascular endothelial growth factor-stimulated in vitro angiogenesis in the hypoxic mouse heart. Cardiovascular research 80, 106–113.
   PubMed Web of Science ®Google Scholar
• Shen, M., Ma, L. and Zhao, M.M. 2014. Experimental study for expression change of exercise-induced bradykinin. Cardiovascular rehabilitation Medicine, 1, 26–30.
   Google Scholar
• Silva, J.A., Jr, et al. 2000. Reduced cardiac hypertrophy and altered blood pressure control in transgenic rats with the human tissue kallikrein gene. FASEB journal, 14, 1858–1860.
   PubMed Web of Science ®Google Scholar
• Yu, H.S., et al. 2014. Bradykinin promotes vascular endothelial growth factor expression and increases angiogenesis in human prostate cancer cells. Biochemical pharmacology, 87, 243–253.
   PubMed Web of Science ®Google Scholar